Key Lessons & Opportunities in applying NCA and PopPK to ADCs
Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…
CertaraOctober 24, 2025
Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling
QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…
CertaraOctober 22, 2025
Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling
Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…
CertaraOctober 16, 2025
Immuno-oncology (IO) Simulator in Certara IQ™
Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…
CertaraOctober 16, 2025
ADC Modeling and Design with Certara IQ™
Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…
CertaraOctober 16, 2025
Prebuilt Pharmacology Models in Certara IQ™
Certara IQ Pharmacology Models | Prebuilt Mechanistic Models for Faster QSP Research
CertaraOctober 16, 2025
QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™
Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…
CertaraOctober 16, 2025
Modeling Alzheimer’s Disease with Certara IQ™
Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…
CertaraOctober 16, 2025
Early Feasibility Assessment (EFA) with Certara IQ™
Learn how Certara IQ performs early feasibility assessments (EFA) to predict biotherapeutic dosing, guide candidate…
CertaraOctober 16, 2025
